Lymphatic vessel density in the neoplastic progression of Barrett's oesophagus to adenocarcinoma

被引:14
|
作者
Brundler, MA
Harrison, JA
de Saussure, B
de Perrot, M
Pepper, MS
机构
[1] Univ Geneva, Med Ctr, Dept Clin Pathol, CH-1211 Geneva 4, Switzerland
[2] Univ Geneva, Med Ctr, Dept Morphol, CH-1211 Geneva 4, Switzerland
[3] Birmingham Childrens Hosp, Birmingham B4 6NH, W Midlands, England
[4] Unitas Hosp, NetCare Mol Med Inst, ZA-0140 Pretoria, South Africa
关键词
D O I
10.1136/jcp.2005.028118
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Background: Oesophageal adenocarcinoma is an aggressive neoplasm with poor prognosis as a result of early lymph node metastasis. Aims: To measure lymphatic vessel density (LVD) in the neoplastic progression from Barrett's metaplasia to adenocarcinoma and determine whether LVD can predict the risk of cancer. In addition, to correlate LVD with lymph node metastasis and assess whether LVD could be used as a prognostic indicator for outcome or survival. Methods: LVD and microvascular density (MVD) were assessed after immunohistochemical staining of vessels in Barrett's metaplasia, dysplasia, and adenocarcinoma tissues and were correlated with clinicopathological features. Results: LVD was significantly reduced in adenocarcinoma, being half that seen in normal stomach/oesophagus or metaplasia/dysplasia. LVD did not correlate with tumour grade, stage, or clinical outcome; however, patients who had either lymph node metastasis or invasion of tumour cells into peritumorous lymphatic vessels had a significantly worse overall survival. MVD was also assessed as a prognostic marker; its increase appeared to be linked more with the development of Barrett's metaplasia than adenocarcinoma. Conclusions: The reduction in lymphatic vessel numbers was not useful for determining disease outcome in the patient group studied. It is the entry of tumour cells into pre-existing peritumorous lymphatic vessels that confers a significantly worse overall survival.
引用
收藏
页码:191 / 195
页数:5
相关论文
共 50 条
  • [1] New models of neoplastic progression in Barrett's oesophagus
    Pavlov, Kirill
    Maley, Carlo C.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2010, 38 : 331 - 336
  • [2] Genetic progression of Barrett's oesophagus to oesophageal adenocarcinoma
    Gregson, Eleanor M.
    Bornschein, Jan
    Fitzgerald, Rebecca C.
    BRITISH JOURNAL OF CANCER, 2016, 115 (04) : 403 - 410
  • [3] Genetic progression of Barrett’s oesophagus to oesophageal adenocarcinoma
    Eleanor M Gregson
    Jan Bornschein
    Rebecca C Fitzgerald
    British Journal of Cancer, 2016, 115 : 403 - 410
  • [4] THE CLONAL PROGRESSION OF BARRETT'S OESOPHAGUS TO OESOPHAGEAL ADENOCARCINOMA
    Khan, S.
    Zeki, S.
    Mitchell, I.
    Harrison, R.
    Dunn, L.
    Leedham, S.
    Barr, H.
    Shepherd, N.
    Graham, T.
    Wright, N.
    McDonald, S.
    GUT, 2012, 61 : A36 - A37
  • [5] Cell cycle phase distribution in neoplastic progression of Barrett's oesophagus
    Lao-Sirieix, P
    Brais, R
    Coleman, N
    Fitzgerald, R
    GUT, 2004, 53 : A26 - A26
  • [6] Endoscopic risk factors for neoplastic progression in patients with Barrett's oesophagus
    Gonzalez, Angela Bureo
    Bergman, Jacques J. G. H. M.
    Pouw, Roos E.
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2016, 4 (05) : 657 - 662
  • [7] Cell cycle phase distribution in neoplastic progression of Barrett's oesophagus
    Lao-Sirieix, P
    Brais, RJ
    Coleman, N
    Fitzgerald, R
    GASTROENTEROLOGY, 2004, 126 (04) : A651 - A651
  • [8] Social class and progression of Barrett's oesophagus to oesophageal adenocarcinoma
    Bhattacharjee, Santanu
    Caygill, Christine P. J.
    Watson, Anthony
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2020, 32 (01) : 131 - 132
  • [9] The role of antioxidant vitamins in the progression of Barrett's oesophagus to adenocarcinoma
    Fountoulakis, A
    Martin, IG
    White, K
    Hardie, LJ
    Sue-Ling, HM
    Wild, CP
    BRITISH JOURNAL OF SURGERY, 2001, 88 : 54 - 54
  • [10] Barrett's oesophagus and adenocarcinoma
    Caygill C.P.J.
    Watson A.
    Lao-Sirieix P.
    Fitzgerald R.C.
    World Journal of Surgical Oncology, 2 (1)